|
|||||
|
|
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations |
|
| Authors: | Takayuki Yoshino Yoshito Komatsu Yasuhide Yamada Kentaro Yamazaki Akihito Tsuji Takashi Ura Axel Grothey Eric Van Cutsem Andrea Wagner Frank Cihon Yoko Hamada Atsushi Ohtsu |
| Affiliation: | 1. Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, 277-8577, Chiba, Japan 2. Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan 3. Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan 4. Gastrointestinal Oncology, Shizuoka Cancer Center, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan 13. Kobe City Hospital Organization, Kobe City Medical Center General Hospital, Kobe, Japan 5. Department of Medical Oncology, Kochi Health Sciences Center, Kochi, Japan 6. Department of Clinical Oncology, Aichi Cancer Center Hospital, Chikusa-ku, Nagoya, Aichi, Japan 7. Department of Oncology, Mayo Clinic, Rochester, MN, USA 8. Digestive Oncology, University Hospitals and KU Leuven, Leuven, Belgium 9. Global Clinical Development–Oncology, Bayer Pharma AG, Berlin, Germany 10. Global Biostatistics, Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA 11. Medical Affairs, Oncology & Hematology, Bayer Yakuhin Ltd, Osaka, Japan 12. Exploratory Oncology Research & Clinical Trial Center, National Cancer Center Hospital East, Kashiwa, Chiba, Japan |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |